Stay updated with breaking news from Nasdaq Fdmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 3,220,000 shares, a drop of 18.1% from the December 15th total of 3,930,000 shares. Based on an average daily volume of 366,600 […]
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) and Disc Medicine (NASDAQ:IRON – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Volatility and Risk 4D Molecular Therapeutics […]
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month […]
Royal Bank of Canada initiated coverage on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a report published on Thursday, Briefing.com reports. The brokerage issued an outperform rating and a $25.00 target price on the stock. Several other equities analysts have also commented on FDMT. HC Wainwright restated a buy rating and set […]